Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$204M |
| 2 |
Peloton Interactive
PTON
|
+$199M |
| 3 |
Ecolab
ECL
|
+$185M |
| 4 |
Canadian National Railway
CNI
|
+$176M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$740M |
| 2 |
Microsoft
MSFT
|
+$500M |
| 3 |
Visa
V
|
+$424M |
| 4 |
Texas Instruments
TXN
|
+$369M |
| 5 |
Verizon
VZ
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Healthcare | 13.35% |
| 3 | Financials | 11.66% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Zai Lab
ZLAB
$2.91B
| $4.65M | ﹤0.01% |
74,016
-90,998
| -55% | -$7.72M |
|
2502
Winmark
WINA
$1.26B
| $4.65M | ﹤0.01% |
18,727
-1,129
| -6% | -$273K |
|
2503
Alpha and Omega Semiconductor
AOSL
$921M
| $4.64M | ﹤0.01% |
76,708
+522
| +0.7% | +$22.6K |
|
|
RXDX
2504
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $4.62M | ﹤0.01% |
116,782
+82,928
| +245% | +$2.6M |
|
2505
Axsome Therapeutics
AXSM
$11.2B
| $4.61M | ﹤0.01% |
121,979
-24,427
| -17% | -$899K |
|
2506
Origin Bancorp
OBK
$1.68B
| $4.61M | ﹤0.01% |
107,279
+4,814
| +5% | +$211K |
|
2507
Paysafe
PSFE
$340M
| $4.6M | ﹤0.01% |
98,077
+38,824
| +66% | +$2.6M |
|
2508
iShares Biotechnology ETF
IBB
$9.73B
| $4.6M | ﹤0.01% |
30,132
-1,640
| -5% | -$254K |
|
2509
Liberty Media Series A
FWONA
$23.9B
| $4.6M | ﹤0.01% |
80,896
-1,386
| -2% | -$71.6K |
|
2510
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $4.58M | ﹤0.01% |
105,798
+42,312
| +67% | +$1.84M |
|
2511
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $4.58M | ﹤0.01% |
34,553
+2,925
| +9% | +$389K |
|
2512
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$423M
| $4.57M | ﹤0.01% |
184,343
+2,166
| +1% | +$54K |
|
|
KE
2513
Kimball Electronics
KE
$622M
| $4.57M | ﹤0.01% |
209,914
-15,793
| -7% | -$396K |
|
|
TBRG
2514
DELISTED
TruBridge
TBRG
| $4.57M | ﹤0.01% |
155,893
-18,672
| -11% | -$609K |
|
2515
Tredegar Corp
TG
$276M
| $4.56M | ﹤0.01% |
386,013
-23,767
| -6% | -$286K |
|
2516
UWM Holdings
UWMC
$2.55B
| $4.56M | ﹤0.01% |
770,718
+628,106
| +440% | +$4.24M |
|
|
GDEN
2517
DELISTED
Golden Entertainment
GDEN
| $4.55M | ﹤0.01% |
90,147
+18,481
| +26% | +$915K |
|
2518
Alignment Healthcare
ALHC
$2.9B
| $4.53M | ﹤0.01% |
322,002
+222,057
| +222% | +$3.89M |
|
2519
Vishay Precision Group
VPG
$969M
| $4.52M | ﹤0.01% |
121,855
-1,012
| -0.8% | -$36.2K |
|
|
RVNC
2520
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.51M | ﹤0.01% |
276,244
+5,691
| +2% | +$94.9K |
|
2521
Argan
AGX
$8.11B
| $4.5M | ﹤0.01% |
116,299
+5,939
| +5% | +$248K |
|
2522
Tactile Systems Technology
TCMD
$548M
| $4.47M | ﹤0.01% |
234,982
+15,437
| +7% | +$438K |
|
2523
Sterling Infrastructure
STRL
$17.6B
| $4.46M | ﹤0.01% |
169,470
-36,223
| -18% | -$932K |
|
2524
Allogene Therapeutics
ALLO
$708M
| $4.46M | ﹤0.01% |
298,678
-20,127
| -6% | -$355K |
|
|
SRNE
2525
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $4.46M | ﹤0.01% |
958,261
-204,124
| -18% | -$1.27M |
|
Similar funds
Bank of New York Mellon's Q4 2021 Portfolio in Review
As of Q4 2021, Bank of New York Mellon held 4,753 positions worth $554B, up 8.2% from $512B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2021 filing shows 234 new, 2,052 increased, 1,966 reduced and 138 closed positions. Its largest new stake was Rivian: 608,811 shares worth $63.1M. The largest sale was Apple, an estimated $740M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2021 buy was Rivian: 608,811 shares worth $63.1M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $204M increase.
- Bank of New York Mellon's biggest Q4 2021 reduction was Apple, cutting an estimated $740M.
- Bank of New York Mellon fully exited Kansas City Southern in Q4 2021, selling an estimated $195M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $554B portfolio in Q4 2021.
- Bank of New York Mellon opened 234 new positions and closed 138 in Q4 2021.
- Bank of New York Mellon's portfolio value rose 8.2% quarter-over-quarter to $554B.
Based on Bank of New York Mellon's 13F filing for Q4 2021, filed 11 Feb 2022.